XENE icon

Xenon Pharmaceuticals

60 hedge funds and large institutions have $173M invested in Xenon Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 10 closing their positions.

Holders
60
Holders Change
-3
Holders Change %
-4.76%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
18
Reduced
13
Closed
10
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$9K
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
51
Morgan Stanley
New York
$61K +$12.3K +1,241 +25%
UBS Group
52
UBS Group
Switzerland
$51K +$21.1K +2,123 +71%
CSS
53
Cubist Systematic Strategies
Connecticut
$44K -$26.5K -2,690 -38%
CFGS
54
Concourse Financial Group Securities
Alabama
$20K +$10K +1,000 +100%
Deutsche Bank
55
Deutsche Bank
Germany
$19K -$16K -1,719 -46%
Citigroup
56
Citigroup
New York
$10K +$2.46K +246 +33%
LC
57
Lindbrook Capital
California
$7K +$7K +750 New
Wells Fargo
58
Wells Fargo
California
$3K
Daiwa Securities Group
59
Daiwa Securities Group
Japan
$2K
SFM
60
Sphera Funds Management
Israel
-$5.42M -533,655 Closed
SSA
61
Schonfeld Strategic Advisors
New York
-$5.08M -500,000 Closed
SCM
62
Stonepine Capital Management
Oregon
-$1M -98,860 Closed
IPC
63
Invesco Private Capital
New York
-$808K -79,539 Closed
Two Sigma Investments
64
Two Sigma Investments
New York
-$591K -58,149 Closed
Millennium Management
65
Millennium Management
New York
-$491K -48,286 Closed
WG
66
Winton Group
United Kingdom
-$132K -13,012 Closed
Goldman Sachs
67
Goldman Sachs
New York
-$124K -12,246 Closed
TRCT
68
Tower Research Capital (TRC)
New York
-$19K -1,870 Closed